GlaxoSmithKline
GSK
#183
Rank
$85.66 B
Marketcap
$42.22
Share price
0.14%
Change (1 day)
21.25%
Change (1 year)

EPS for GlaxoSmithKline (GSK)

EPS in 2023 (TTM): $3.50

According to GlaxoSmithKline's latest financial reports the company's current EPS (TTM) is $3.50. In 2022 the company made an earnings per share (EPS) of $8.48 an increase over its 2021 EPS that were of $2.99.

EPS history for GlaxoSmithKline from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$3.50-58.72%
2022$8.48183.39%
2021$2.99-17.83%
2020$3.6421.82%
2019$2.9923.91%
2018$2.41141.48%
2017$1.0064.6%
2016$0.61-90.64%
2015$6.48178.14%
2014$2.33-48.16%
2013$4.5022.63%
2012$3.67-11.32%
2011$4.14230.25%
2010$1.25-70.98%
2009$4.326.76%
2008$4.04-15.14%
2007$4.767.82%
2006$4.4219.61%
2005$3.6918.56%
2004$3.120.36%
2003$3.1050.39%
2002$2.0631.13%
2001$1.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.74 6.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$1.86-46.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.18-9.15%๐Ÿ‡ซ๐Ÿ‡ท France
$1.82-47.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.98-43.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$2.00-157.13%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$0.87-75.15%๐Ÿ‡บ๐Ÿ‡ธ USA